Combination treatment is well-tolerated, shows antitumor effects in KRAS G12C-mutated metastatic colorectal cancer

📆 4/8/2024 4:32 PM
📰 medical_xpress

⏱ Reading Time:
45 sec. here
7 min. at publisher
📊 Quality Score:
News: 38%
Publisher: 51%

Medicine Research News News

Medicine Research,Health Research News,Health Research

Combining the KRAS G12C inhibitor adagrasib with the anti-EGFR antibody cetuximab demonstrated promising anti-tumor effects in patients with KRAS G12C-mutated metastatic colorectal cancer (CRC), according to pooled results from the Phase I/II KRYSTAL-1 trial reported by researchers from The University of Texas MD Anderson Cancer Center.

Combination treatment is well-tolerated, shows antitumor effects in KRAS G12C-mutated metastatic colorectal cancer retrieved 8 April 2024 from https://medicalxpress.com/news/2024-04-combination-treatment-tolerated-antitumor-effects.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.1 hour agoUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor typesA pair of medications that make malignant cells act as if they have a virus could hold new promise for treating colorectal cancers and other solid tumors, reports a study published in Science Advances.
Source: medical_xpress - 🏆 101. / 51 Read more »

New research highlights combining prostate MRI with a blood test to avoid unnecessary prostate biopsiesMRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests
Source: medical_xpress - 🏆 101. / 51 Read more »

Combining MRI and blood tests to avoid unnecessary prostate biopsiesMRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests.
Source: NewsMedical - 🏆 19. / 71 Read more »